Delisting Determination, The Nasdaq Stock Market, LLC, January 13, 2026
Protagenic Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Protagenic Therapeutics, Inc. effective at the
opening of the trading session on February 2, 2026. Based on review
of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(b)(1).The Company was
notified of the Staff determination on November 20, 2025.
On November 28, 2025 the Company exercised its right to appeal
the Staff determination to the Listing Qualifications Hearings
Panel (Panel) pursuant to Listing Rule 5815.
On December 31, 2025 the Company withdrew its appeal
of Staff's Delist Determination letter so the
Hearing was canceled.
The Company securities were suspended on January 5, 2026. The
Staff determination to delist the Company securities
became final on January 5, 2026.